Coronary diseaseSponsored Symposia

SOLACI-CACI 2021 | Using the MLD MAX Algorithm in OCT-Guided PERCUTANEOUS CORONARY INTERVENTIONS – ABBOTT Symposium

solaci
solaci
564
0

✔️ Watch again the ABBOTT Symposium in the SOLACI-CACI 2021 Virtual Congress.
✔️ Topic: Using the MLD MAX Algorithm in OCT-Guided Percutaneous Coronary Interventions.

👨‍🏫 Program:

  • 00:05 – Introduction- Dr. Alejandro Cherro (ARG).
  • 02:34 – Concepts on the Treatment of Complex and Challenging Optical Coherence Tomography (OCT) – Guided Cases Using MLD MAX – Dr. Natalia Pinilla (CAN), Dr. Jorge Chavarría (COS / CAN) – Discussion of a Clinical Case.

👉 Moderator: Dr. Alejandro Cherro (ARG).
👉 Speakers: Dr. Natalia Pinilla (Canada), Dr. Jorge Chavarría (Costa Rica/Canada)

This event took place on August 3rd, 2021.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Previous article
SOLACI-CACI 2021 | Overcoming Challenges of the BALLOON EXPANDABLE TAVI Cases – EDWARDS Symposium
Next article
SOLACI-CACI 2021 | SELUTION SLR DEB – Changing the Treatment Paradigm for Complex Lesions – Medalliance Symposium
solaci
solaci

More articles by this author

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 0
The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Dr. Omar Tupayachi - 0
Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...

CRT 2026 | CUT-DRESS Trial: Lesion Preparation with Cutting Balloon

Dr. Omar Tupayachi - 0
In-stent restenosis (ISR) continues to represent a relevant clinical challenge in contemporary coronary angioplasty practice. Despite advances in drug-eluting stents, neointimal hyperplasia and suboptimal...

CRT 2026 | Clopidogrel vs Aspirin as Long-Term Monotherapy After Coronary Angioplasty

Dr. Omar Tupayachi - 0
The use of aspirin as chronic antiplatelet therapy after percutaneous coronary intervention (PCI) has historically been the standard recommended by international guidelines. However, recent...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

Acute coronary syndromes

Drugs for the Treatment of No-Reflow During PCI

The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in...
Dr. Omar Tupayachi -
SOLACI Sessionsspot_img

Recent Articles

Drugs for the Treatment of No-Reflow During PCI

Dr. Omar Tupayachi - 0
The no-reflow phenomenon is one of the most frustrating complications of primary angioplasty (pPCI), reflecting persistent microvascular damage that, in the mid- to long-term,...

Coronary revascularization before TAVI: prior PCI or conservative management?

Dr. Juan Manuel Pérez - 0
The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

Rotational atherectomy and its technical secrets: use of floppy or ES guidewire

Dr. Omar Tupayachi - 0
Rotational atherectomy (RA) remains a very useful tool in the management of severe coronary calcification. However, many of its technical aspects rely more on...